Filing Details
- Accession Number:
- 0001209191-17-044766
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-11 16:07:50
- Reporting Period:
- 2017-07-07
- Filing Date:
- 2017-07-11
- Accepted Time:
- 2017-07-11 16:07:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578696 | David Davidson | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-07-07 | 1,100 | $100.43 | 16,077 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-07 | 100 | $101.10 | 15,977 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2016.
- The range of prices for the transaction reported on this line was $100.05 to $100.60. The average weighted price was $100.4297. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
